Literature DB >> 20212993

Invasive group A streptococcal infections.

.   

Abstract

Entities:  

Year:  1999        PMID: 20212993      PMCID: PMC2828231          DOI: 10.1093/pch/4.1.73

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  13 in total

1.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

2.  Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections.

Authors: 
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

3.  Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates.

Authors:  M C Wheeler; M H Roe; E L Kaplan; P M Schlievert; J K Todd
Journal:  JAMA       Date:  1991 Jul 24-31       Impact factor: 56.272

4.  An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.

Authors:  F R Cockerill; K L MacDonald; R L Thompson; F Roberson; P C Kohner; J Besser-Wiek; J M Manahan; J M Musser; P M Schlievert; J Talbot; B Frankfort; J M Steckelberg; W R Wilson; M T Osterholm
Journal:  JAMA       Date:  1997-01-01       Impact factor: 56.272

Review 5.  Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults.

Authors:  H D Davies; A Matlow; S R Scriver; P Schlievert; M Lovgren; J A Talbot; D E Low
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

6.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

7.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

8.  Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.

Authors:  A Norrby-Teglund; R Kaul; D E Low; A McGeer; D W Newton; J Andersson; U Andersson; M Kotb
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

9.  Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella.

Authors:  A Doctor; M B Harper; G R Fleisher
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  4 in total

1.  Flesh-eating disease: A note on necrotizing fasciitis.

Authors:  H D Davies
Journal:  Can J Infect Dis       Date:  2001-05

2.  Flesh-eating disease: A note on necrotizing fasciitis.

Authors:  H D Davies
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

3.  Case 1: Pneumonia with hypotension and a rash.

Authors:  Ronik Kanani; W Gary Smith
Journal:  Paediatr Child Health       Date:  2004-09       Impact factor: 2.253

4.  Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011-2016.

Authors:  Vicky Watts; Sooria Balasegaram; Colin S Brown; Suzanna Mathew; Rachel Mearkle; Derren Ready; Vanessa Saliba; Theresa Lamagni
Journal:  Emerg Infect Dis       Date:  2019-03-17       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.